Mutation Testing

Summary

Are you a security researcher looking to work side by side with the best in the industry? Apply to open positions at Guardian here: ... Is your patient progressing on an aromatase inhibitor (AI)? Fine-tune ddPCR/NGS Now that we've seen some pros and cons how does What if molecular progression gives us a critical window to intervene before patients ever become symptomatic? Drs. Megan ... Biomarker Testing, Genomic Testing, Genetic In this first video in a two-part series, join Jordan Leven as he explains what Sanam Loghavi, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the challenges and feasibility ... For translational and clinical research in hemato-oncology, the ability to identify and measure rare nucleic acid (NA) sequences is ... Mark G. Kris, MD. Chief, Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center in New York Discusses EGFR ...